Sanuwave Health Selected for Inclusion in Russell 2000® Index

Core Insights - Sanuwave Health, Inc. has been included in the Russell 2000® Index as part of the 2025 Russell indexes reconstitution, effective June 30, 2025 [1] - The company will also be included in the broader Russell 3000® Index and the Russell Microcap® Index [1] Group 1: Company Overview - Sanuwave Health focuses on the research, development, and commercialization of patented, non-invasive medical systems aimed at repairing and regenerating skin, musculoskeletal tissue, and vascular structures [4] - The company's wound care portfolio includes regenerative medicine products that assist in restoring normal healing processes [5] - Sanuwave utilizes patented energy transfer technologies across various medical fields, including wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions [5] Group 2: Industry Context - The Russell U.S. indexes encompass the 4,000 largest U.S. stocks ranked by total market capitalization as of April 30 each year [2] - Membership in the Russell 3000® Index leads to automatic inclusion in either the Russell 1000® Index or the Russell 2000® Index, along with relevant growth and value style indexes [2] - As of June 2024, approximately $10.6 trillion in assets were benchmarked to the Russell U.S. indexes, which are maintained by FTSE Russell [3]